Nanjing Medlander Medical Technology Co (SHSE:688273) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nanjing Medlander Medical Technology Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Nanjing Medlander Medical Technology Co's long-term debt to total assets ratio declined from Mar. 2023 (0.00) to Mar. 2024 (0.00). It may suggest that Nanjing Medlander Medical Technology Co is progressively becoming less dependent on debt to grow their business.

Nanjing Medlander Medical Technology Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co LT-Debt-to-Total-Asset Chart

Nanjing Medlander Medical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Nanjing Medlander Medical Technology Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial												-	-	-	-	-

Nanjing Medlander Medical Technology Co LT-Debt-to-Total-Asset Calculation

Nanjing Medlander Medical Technology Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2.374	/	1533.924
	=	0.00

Nanjing Medlander Medical Technology Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	2.062	/	1554.515
	=	0.00

Nanjing Medlander Medical Technology Co (SHSE:688273) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Nanjing Medlander Medical Technology Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100

Website

http://www.medlander.com

Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.

Executives

Zhu Bi Sheng	senior management
Chen Jiang Ning	senior management
Yang Rui Jia	Directors, senior managers, core technical personn
Shi Zhi Huai	Directors, senior managers, core technical personn
Chen Bin	Directors, senior managers
Tu Hong Lin	Directors, senior managers
Wang Wang	senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines